ADVFN US – Market Content Editor
-
DEFSEC Shares Slide Following Announcement of Equity Offering
Shares of DEFSEC Technologies Inc. (NASDAQ:DFSC) dropped 17.7% on Wednesday after the cybersecurity company revealed plans for a registered direct share offering alongside a concurrent private placement involving shares and warrants. Under the terms of the transaction, DEFSEC intends to issue 566,040 common shares at a price of CAD$3.64 (US$2.65) per share through the registered…
-
Processa Pharmaceuticals Shares Surge on Encouraging Cancer Trial Update
Shares of Processa Pharmaceuticals Inc. (NASDAQ:PCSA) jumped 23.8% on Wednesday after the company reported early Phase 2 clinical data indicating that its Next Generation Cancer (NGC) therapy achieved higher exposure to cancer-fighting metabolites while maintaining a safety profile comparable to existing treatments. The clinical-stage biotech company said results from 16 of the 19 patients enrolled…
-
Vistagen Shares Collapse After Phase 3 Anxiety Drug Trial Misses Goal
Shares of Vistagen (NASDAQ:VTGN) plunged 78.8% on Wednesday after the biopharmaceutical company disclosed that its Phase 3 clinical trial of fasedienol for social anxiety disorder failed to achieve its primary endpoint. The late-stage drug developer said the PALISADE-3 study did not show a statistically meaningful reduction in anxiety symptoms compared with placebo. Results indicated a…
-
Moleculin Biotech Shares Slide After Release of Pediatric Brain Tumor Trial Data
Moleculin Biotech Inc. (NASDAQ:MBRX) shares fell 9.1% in premarket trading on Wednesday after the company disclosed results from a Phase 1 clinical study evaluating its drug candidate WP1066 in pediatric patients with brain tumors. The study, sponsored by Emory University and carried out at the Aflac Cancer and Blood Disorders Center at Children’s Healthcare of…
-
Compugen Shares Jump After $65 Million Royalty Monetization Deal With AstraZeneca
Shares of Compugen Ltd. (NASDAQ:CGEN) rose 12.8% in premarket trading on Wednesday after the company unveiled a strategic agreement with AstraZeneca to monetize part of its future royalty stream tied to the cancer therapy rilvegostomig. Under the non-dilutive arrangement, Compugen will receive an upfront payment of $65 million, with the potential to earn an additional…
-
Toro Shares Climb After Earnings Beat and Upgraded 2026 Outlook
Shares of The Toro Company (NYSE:TTC) rose 3.2% in premarket trading on Wednesday after the outdoor power equipment maker delivered fourth-quarter results that topped expectations and issued an upbeat forecast for fiscal 2026. Toro reported adjusted earnings of $0.91 per share for the fourth quarter, slightly ahead of analyst estimates of $0.90. Quarterly revenue totaled…
-
QuantumScape Shares Jump on Joint Development Deal With Major Automaker
QuantumScape Corp (NYSE:QS) shares rose 6.6% in premarket trading on Wednesday after the solid-state battery company announced it had entered into a joint development agreement (JDA) with a Top-10 global automotive manufacturer. QuantumScape, which is focused on advancing solid-state lithium-metal battery technology, said the agreement marks the completion of its final strategic objective for 2025.…
-
Two Harbors Shares Rally on $1.3 Billion All-Stock Takeover by UWM Holdings
Shares of Two Harbors Investment Corp (NYSE:TWO) jumped 6.2% in premarket trading on Wednesday after UWM Holdings Corporation (NYSE:UWMC) revealed plans to acquire the mortgage servicing rights–focused REIT in an all-stock deal valued at approximately $1.3 billion. Under the agreement, Two Harbors shareholders will receive 2.3328 shares of UWMC Class A common stock for each…
-
ZIM Shares Edge Higher After Company Reaches Deal to Resolve Proxy Dispute
ZIM Integrated Shipping Services Ltd. (NYSE:ZIM) shares gained 2.1% in premarket trading on Wednesday after the shipping company said it had reached an agreement with a group of shareholders, bringing an end to a proxy battle ahead of its upcoming annual meeting. Under the agreement, reached with a shareholder group led by Mor Gemel Pension…
-
Udemy Shares Jump After Coursera Agrees to Acquire Company in Stock-Only Deal
Shares of Udemy (NASDAQ:UDMY) surged 25.7% in premarket trading on Wednesday after education technology peer Coursera (NYSE:COUR) announced an agreement to acquire the online learning platform through an all-stock transaction. Coursera’s own shares also moved higher, rising 10% ahead of the market open. Under the terms of the deal, Udemy shareholders will receive 0.800 shares…